These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18323593)

  • 1. [Development of the technology of the substance of davikol and standardization].
    Bakuridze A; Shengelia D; Kurdiani N; Mikaia G; Karanadze N
    Georgian Med News; 2008 Jan; (154):43-7. PubMed ID: 18323593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental investigation of general toxiology of antioxidant eyedrops davicol].
    Shengeliia DG; Bakuridze AD; Karanadze NA; Mikaia GA; Baliashvili VS
    Georgian Med News; 2007 Apr; (145):88-90. PubMed ID: 17525510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial agents in eyedrops].
    Sklubalová Z
    Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
    Kodym A; Marcinkowski A; Kukuła H
    Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ophthalmic lyophilisate carrier system (OLCS): development of a novel dosage form, freeze-drying technique, and in vitro quality control tests.
    Süverkrüp R; Grunthal S; Krasichkova O; Maier S; Weichselbaum A; Neff B; Diestelhorst M; Dinslage S; Lux A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):269-77. PubMed ID: 15018984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The sterilization of ophthalmic solutions].
    Pănescu C
    Oftalmologia; 1991; 35(1):69-74. PubMed ID: 1811743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of technology of sodium cromoglycate eye drops].
    Inkeniene AM; Klimas R; Ramanauskiene K
    Medicina (Kaunas); 2005; 41(7):584-91. PubMed ID: 16062026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Soluble tablets for the preparation of eye drops].
    Smazyński T; Krówczyński L
    Acta Pol Pharm; 1968 Jun; 25(3):291-8. PubMed ID: 5680565
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physical and chemical stability of fortified ophtalmic ready-to-use solutions: review of literature].
    Sourdeau P; Evrard JM; Remy G; Hecq JD
    Ann Pharm Fr; 2012 Mar; 70(2):104-12. PubMed ID: 22500962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dosage case for ophthalmic medicated films].
    Khromov GL; Shelukhanov GV; Davydov AB; Nazhestkin KP
    Med Tekh; 1975; (6):44-5. PubMed ID: 1230631
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study.
    Troiano P; Monaco G
    Cornea; 2008 Dec; 27(10):1126-30. PubMed ID: 19034126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved extemporaneous formulation of cyclosporine ophthalmic drops.
    Mueller DW
    Am J Hosp Pharm; 1994 Dec; 51(24):3080-1. PubMed ID: 7856631
    [No Abstract]   [Full Text] [Related]  

  • 13. Mobile infusion pumps for continuous delivery of fluid and therapeutic agents to the eye.
    Dohlman CH; Doane MG; Reshmi CS
    Ann Ophthalmol; 1971 Feb; 3(2):126-8. PubMed ID: 5164421
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiglaucoma drops--with or without preservatives].
    Zemba M
    Oftalmologia; 2009; 53(2):26-30. PubMed ID: 19697836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin.
    Seelinger G; Merfort I; Schempp CM
    Planta Med; 2008 Nov; 74(14):1667-77. PubMed ID: 18937165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G; O'Brien TP
    Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.
    Baudouin C
    Acta Ophthalmol; 2008 Nov; 86(7):716-26. PubMed ID: 18537937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quick filtration of eye drops in pharmacy prescriptions].
    Poggendorf A; Kaubisch E
    Pharm Prax; 1970 Oct; 10():230-3. PubMed ID: 5492662
    [No Abstract]   [Full Text] [Related]  

  • 19. Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops.
    Bradley JC; Simoni J; Bradley RH; McCartney DL; Brown SM
    Cornea; 2009 Feb; 28(2):200-5. PubMed ID: 19158565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compounding in veterinary ophthalmology.
    Malmberg GJ; Lupo R
    Vet Clin North Am Small Anim Pract; 2004 May; 34(3):825-38. PubMed ID: 15110986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.